Studies on the inhibition of human cytochromes P450 by selenocysteine Se-conjugates

Xenobiotica

Volumn 33, Issue 1, 2003, Pages 57-72

  Venhorst, J ^a   Rooseboom, M ^a   Vermeulen, N P E ^a   Commandeur, J N M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; GLUTATHIONE; LYASE; REACTIVE OXYGEN METABOLITE; SELENIUM BENZYL SELENOCYSTEINE; SELENIUM DERIVATIVE; SELENIUM PHENYL SELENOCYSTEINE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; DRUG ACETYLATION; DRUG ACTIVATION; DRUG POTENCY; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; PROTEIN EXPRESSION;

ACETYLATION; BINDING, COMPETITIVE; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; FLUORESCENT DYES; HUMANS; ISOENZYMES; KINETICS; SELENIUM; SELENOCYSTEINE;

LETHRINIDAE;

EID: 0037232813     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/0049825021000022357     Document Type: Article

References (45)

1. Andreadou, I., Menge, W. M. P. B., Commandeur, J. N. M., Worthington, E. A. and Vermeulen, N. P. E., 1996, Synthesis of novel Se-substituted selenocysteine derivatives as potential kidney selective prodrugs of biologically active selenol compounds: Evaluation of kinetics of β-elimination reactions in rat renal cytosol. Journal of Medicinal Chemistry, 39, 20402046.
2. Brenner, M. and Huber, W., 1953. Herstellung von α-aminosäureestern durch alkoholyse der methylester. Helvetica, 36, 1109-1115.
3. Commandeur, J. N. M., Andreadou, I., Rooseboom, M., Out, M., De Leur, L. J., Groot, E. and Vermeulen, N. P. E., 2000, Bioactivation of selenocysteine Se-conjugates by a highly purified rat renal cysteine conjugate beta-lyase/glutamine transaminase K. Journal of Pharmacology and Experimental Theropeutics, 294, 753-761.
4. Commandeur, J. N. M., Stijntjes, G. J. and Vermeulen, N. P. E., 1995, Enzymes and transport systems involved in the formation and disposition of glutathione-S-conjugates. Role in bioactivation and detoxication mechanisms of xenobiotics. Pharmacological Reviews, 47, 271-330.
5. Conaway, C. C., Jiao, D. and Chung, F. L., 1996, Inhibition of rat liver cytochrome P450 isoenzymes by isothiocyanates and their conjugates: A structure-activity relationship study. Carcinogenesis, 17, 2423-2427.
6. Crespi, C. L., 1999, Higher-throughput screening with human cytochromes P450. Current Opinion in Drug Discovery and Development, 2, 15-19.
7. Crespi, C. L., Miller, V. P. and Penman, B. W., 1997, Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. Analytical Biochemistry, 248, 188-190.
8. Crespi, C. L. and Stresser, D. M., 2000, Fluorimetric screening for metabolism-based drug-drug interactions. Journal of Pharmacological and Toxicological Methods, 44, 325-331.
9. El-Bayoumy, K., 1985, Effects of organoselenium compounds on mouse forestomach tumors by benzo[a]pyrene. Cancer Research, 45, 3631-3635.
10. El-Bayoumy, K., Upadhyaya, P., Chae, Y. H., Sohn, O. S., Rao, C. V., Fiala, E. and Reddy, B. S., 1995, Chemoprevention of cancer by organoselenium compounds. Journal of Cellular Biochemistry, 22 (suppl.), 92-100.
11. Ganther, H. E., 1999, Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase. Carcinogenesis, 20, 1657-1666.
12. Goeptar, A. R., Scheerens, H. and Vermeulen, N. P. E., 1995, Oxygen and xenobiotic reductase activities of cytochrome P450. Critical Reviews in Toxicology, 25, 25-65.
13. Guengerich, F. P. and Shimada, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391-407.
14. Hollenberg, P. F., 2002, Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metabolism Reviews, 34, 17-35.
15. Hyslop, P. A. and Sklar, L. A., 1984, A quantitative fluorimetric assay for the determination of oxygen production by polymorpho-nuclear leukocytes: Its use in the simultaneous fluorimetric assay of cellular activation processes. Analytical Biochemistry, 141, 280-286.
16. Ingelman-Sundberg, M., Oscarson, M. and McLellan, R. A., 1999, Polymorphic human cytochrome P450 enzymes: An opportunity for individualized drug treatment. Trends in Pharmacological Sciences, 20, 342-349.
17. Ioannides, C. and Parke, D. V., 1993, Induction of cytochrome P450 as an indicator of potential chemical carcinogenesis. Drug Metabolism Reviews, 25, 485-501.
18. Ip, C., 1998, Lessons from basic research in selenium and cancer prevention. Journal of Nutrition, 128, 1845-1854.
19. Ip, C. and Lisk, D. J., 1997, Modulation of phase I and phase II xenobiotic-metabolizing enzymes by selenium-enriched garlic in rats. Nutrition and Cancer, 28, 184-188.
20. Ip, C., Vadhanavikit, S. and Ganther, H. E., 1995, Cancer chemoprevention by aliphatic selenocyanates: Effect of chain length on inhibition of mammary tumors and DMBA adducts. Carcinogenesis, 16, 35-38.
21. Ip, C., Zhu, Z., Thompson, H. J., Lisk, D. and Ganther, H. E., 1999, Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Research, 19, 2875-2880.
22. Jiang, C., Jiang, W., Ip, C., Ganther, H. E. and Lu, J., 1999, Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Molecular Carcinogenesis, 26, 213-225.
23. Jiao, D., Conaway, C. C., Wang, M. H., Yang, C. S., Koehl, W. and Chung, F. L., 1996, Inhibition of N-nitrosodimethylamine demethylase in rat and human liver microsomes by isothiocyanates and their glutathione, L-cysteine, and N-acetyl-L-cysteine conjugates. Chemical Research in Toxicology, 9, 932-938.
24. Kawajiri, K. and Hayashi, S.-I., 1997, The CYP1 family. In C. Ioannides (ed.), Cytochromes P450: Metabolic and Toxicological Aspects (London: CRC Press), pp. 77-97.
25. Kent, U. M., Juschyshyn, M. I. and Hollenberg, F. P., 2001, Mechanism-based inactivators as probes of cytochrome P450 structure and function. Current Drug Metabolism, 2, 215-243.
26. Lu, J. X., Pei, H. Y., Lisk, D. J., Ganther, H. and Thompson, H. J., 1996, Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis, 17, 1903-1907.
27. Mugesh, G., Du Mont, W.-W. and Sies, H., 2001, Chemistry of important organoselenium compounds. Chemical Reviews, 101, 2125-2179.
28. Prokopczyk, B., Cox, J. E., Upadhyaya, P., Amin, S., Desai, D., Hoffmann, D. and El-Bayoumy, K., 1996, Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats. Carcinogenesis, 17, 749-753.
29. Puntarola, S. and Cederbaum, A. I., 1998, Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes. Free Radical Biology and Medicine, 24, 1324-1330.
30. Ripp, S. L., Overby, L. H., Philpot, R. M. and Elfarra, A. A., 1997, Oxidation of cysteine S-conjugates by rabbit liver microsomes and cDNA expressed flavin-containing mono-oxygenases: Studies with S-(1,2-dichlorovinyl)-L-cysteine, S-(1,2,2-trichlorovinyl)-L-cysteine, S-allyl-L-cysteine, and S-benzyl-L-cysteine. Molecular Pharmacology, 51, 507-515.
31. Rooseboom, M., Commandeur, J. N. M., Floor, G. C., Rettie, A. E. and Vermeulen, N. P. E., 2001, Selenoxidation by flavin-containing monooxygenases as a novel pathway for β-elimination of selenocysteine Se-conjugates. Chemical Research in Toxicology, 14, 127-134.
32. Rooseboom, M., Vermeulen, N. P. E., Andreadou, I. and Commandeur, J. N. M., 2000, Evaluation of the kinetics of β-elimination reactions of selenocysteine Se-conjugates in human renal cytosol: Possible implications for the use as kidney selective prodrugs. Journal of Pharmacology and Experimental Therapeutics, 294, 762-769.
33. Sausen, P. J. and Elfarra, A. A., 1990, Cysteine conjugate S-oxidase. Characterization of a novel enzymatic activity in rat hepatic and renal microsomes. Journal of Biological Chemistry, 265, 6139-6145.
34. Schaer, E. M., Liu, J. Z., Dangler, C. A. and Milner, J. A., 1996, Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced mammary carcinogenesis. Cancer Letters, 102, 199-204.
35. Schlezinger, J. J., White, R. D. and Stegeman, J. J., 1999, Oxidative inactivation of cytochrome P-450 1A (CYP1A1) stimulated by 3,3′,4,4′-tetrachlorobiphenyl: Production of reactive oxygen by vertebrate CYP1As. Molecular Pharmacology, 56, 588-597.
36. Schwartz, D., Kisselev, P., Cascorbi, I., Schunk, W.-H. and Roots, I., 2001, Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants. Carcinogenesis, 22, 453-459.
37. Shimada, T., El-Bayoumy, K., Upadhyaya, P., Sutter, T. R., Guengerich, F. P. and Yamazaki, H., 1997, Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Cancer Research, 57, 4757-4764.
38. Spatzenegger, M. and Jaeger, W., 1995, Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Reviews, 27, 397-417.
39. Sumioka, I., Matsura, T., Kasuga, S., Itakura, Y. and Yamada, K., 1998, Mechanism of protection of S-allylmercaptocysteine against acetaminophen-induced liver injury in mice. Japanese Journal of Pharmacology, 78, 199-207.
40. Talalay, P., Fahey, J. W., Holtzclaw, W. D., Prestera, T. and Zhang, Y., 1995, Chemoprotection against cancer by phase 2 enzyme induction. Toxicology Letters, 82-83, 173-179.
41. 'T Hoen, P. A., Rooseboom, M., Bijsterbosch, M. K., Van Berkel, T. J., Vermeulen, N. P. E., Commandeur, J. N. M., 2002, Induction of glutathione-S-transferase in RNA levels by chemopreventive selenocysteine Se-conjugates. Biochemical Pharmacology, 63, 1843-1849.
42. Venhorst, J., Onderwater, R. C. A., Meerman, J. H. N., Commandeur, J. N. M. and Vermeulen, N. P. E., 2000, Influence of N-substitution of 7-methoxy-4-(aminomethyl)-coumarin on cytochrome P450 metabolism and selectivity. Drug Metabolism and Disposition, 28, 1524-1532.
43. Werner, M., Birner, G. and Dekant, W., 1996, Sulfoxidation of mercapturic acids derived from tri- and tetrachloroethene by cytochromes P450 3A: A bioactivation reaction in addition to deacetylation and cysteine conjugate beta-lyase mediated cleavage. Chemical Research in Toxicology, 9, 41-49.
44. Werner, M., Guo, Z., Birner, G., Dekant, W. and Guengerich, F. P., 1995, The sulfoxidation of the hexachlorobutadiene metabolite N-acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine is catalyzed by human cytochrome P450 3A enzymes. Chemical Research in Toxicology, 8, 917-923.
45. Yamauchi, A., Stijntjes, G. J., Commandeur, J. M. N. and Vermeulen, N. P. E., 1993, Purification of glutamine transaminase K/cysteine conjugate β-lyase from rat renal cytosol based on hydrophobic interaction HPLC and gel permeation FPLC. Protein Expression and Purification, 4, 552-562.